David James Pinato ๐บ๐ฆ
@DJPinato
Medical Oncologist, MD PhD, Director of Developmental Therapeutics @ImperialCollege & @UniAvogadro โค๏ธ HCC, Immunotherapy and drug development. ๐ฎ๐น ๐ฌ๐ง ๐ณ๏ธโ๐
ID:726462906813059073
30-04-2016 17:27:08
1,4K Tweets
2,2K Followers
1,4K Following
New #JITC position article and guidelines: SITC recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease jitc.bmj.com/content/12/4/eโฆ Jason Luke, MD, FACP Diwakar Davar, M.D. Joshua Brody, MD Greg Goldmacher Howard Kaufman Sherene Loi, MDโฆ
Thank you Society of Abdominal Radiology | SAR Andrei Purysko Sandeep Arora and rest of the outstanding faculty! Honoured to be here for the first workshop testing out PRECISE v2, just hot off the press!Open access here: sciencedirect.com/science/articlโฆ. Spread the word! ๐ฃ๏ธ๐ค๐
Big team effort and important achievement for the group! andrea casadei gardini and Margherita Rimini simply pivotal in orchestrating such a collaborative network ๐
Check out our new paper in #LiverCancer Gastroenterology | Karger โฌ๏ธ
This is a shattering read for any clinician who has their sights on a career in clinical academia in the UK which is hurtling towards extinction. ๐ฆค
โ ๏ธ 36% of CAs are aged >55
โ ๏ธ 65% at Professor grade >55
โ ๏ธ<1% Black/Black British
โ ๏ธ 76% of CAs are men
medschools.ac.uk/news/investmenโฆ
So proud of dalia rosano Luca Magnani for their Cancer Discovery paper on breast cancer dormancy ๐ด ๐ฅ
#ELCC24 I am very grateful for the invite ESMO - Eur. Oncology to discuss immunotherapy and immunosuppression - much more work is required to broaden the reach of immunotherapy in special populations Surgery and Cancer UPO - Universitร
David James Pinato ๐บ๐ฆ engaging the lung-cancer community on how to uncouple immunesuppression from immunestimulation at #ELCC24 Surgery and Cancer UPO - Universitร ESMO - Eur. Oncology ๐ฅ๐ฅ๐ฅ
The best part of my job is to watch stars ๐ rising Giulia Francesca Manfredi FH&L student UPO - Universitร investigating refractoriness to immunotherapy in HCC Surgery and Cancer